Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
PuraPharm Corp. Ltd. ( (HK:1498) ) has issued an announcement.
PuraPharm Corporation Limited has announced a further postponement of its board meeting, originally scheduled to approve the company’s 2024 annual results and consider the payment of a final dividend. This delay, now set for March 31, 2025, indicates additional time is needed to finalize the financial results, which could impact stakeholders’ expectations regarding the company’s financial performance and dividend decisions.
More about PuraPharm Corp. Ltd.
PuraPharm Corporation Limited is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. It focuses on the production and distribution of Chinese medicine products and related services.
YTD Price Performance: 5.45%
Average Trading Volume: 76,611
Technical Sentiment Signal: Buy
Current Market Cap: HK$229.1M
For detailed information about 1498 stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money